Interferon beta-1a decreased the risk for conversion to clinically definite multiple sclerosis
- PMID: 11829562
Interferon beta-1a decreased the risk for conversion to clinically definite multiple sclerosis
Comment on
-
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.Lancet. 2001 May 19;357(9268):1576-82. doi: 10.1016/s0140-6736(00)04725-5. Lancet. 2001. PMID: 11377645 Clinical Trial.